STOCK TITAN

AMYRIS TO HOST SECOND QUARTER 2022 FINANCIAL RESULTS CONFERENCE CALL ON AUGUST 9

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

Amyris, Inc. (Nasdaq: AMRS) announced its financial results for Q2 2022 will be shared on August 9, 2022, before market open. A conference call will follow at 6:00 a.m. PT to discuss these results and provide a business update by CEO John Melo and CFO Han Kieftenbeld. Amyris specializes in sustainable ingredients for Clean Health & Beauty and Flavors & Fragrances markets via its proprietary Lab-to-Market™ platform, reaching over 300 million consumers through 20,000 products.

Positive
  • Leading biotechnology company in sustainable ingredients.
  • Innovative Lab-to-Market™ platform utilizing AI and robotics.
Negative
  • None.

EMERYVILLE, Calif., July 28, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform, today announced that it will issue its financial results for the second quarter ended June 30, 2022, on the morning of Tuesday, August 9, 2022, prior to the opening of the financial markets.

The company will hold a conference call and webcast at 6:00 a.m. Pacific Time (9:00 a.m. Eastern Time), during which, John Melo, President and Chief Executive Officer, and Han Kieftenbeld, Chief Financial Officer, will discuss Amyris' financial results and provide an update on the company's business. Participants may access the live webcast on Amyris' Investor Relations website, where it will be archived for 90 days. The live call can be accessed by dialing (844) 850-0551 (domestic) or (412) 902-4203 (international) and asking to join the Amyris, Inc. call.

About Amyris

Amyris (Nasdaq: AMRS) is a leading synthetic biotechnology company, transitioning the Clean Health & Beauty and Flavors & Fragrances markets to sustainable ingredients through fermentation and the company's proprietary Lab-to-Market™ technology platform. This Amyris platform leverages state-of-the-art machine learning, robotics and artificial intelligence, enabling the company to rapidly bring new innovation to market at commercial scale. Amyris ingredients are included in over 20,000 products from the world's top brands, reaching more than 300 million consumers. Amyris also owns and operates a family of consumer brands that is constantly evolving to meet the growing demand for sustainable, effective and accessible products. For more information, please visit http://www.amyris.com.

Amyris, the Amyris logo and Lab-to-Market are trademarks or registered trademarks of Amyris, Inc. in the U.S. and/or other countries.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/amyris-to-host-second-quarter-2022-financial-results-conference-call-on-august-9-301594896.html

SOURCE Amyris, Inc.

FAQ

When will Amyris release its Q2 2022 financial results?

Amyris will release its Q2 2022 financial results on August 9, 2022.

What time is the Amyris conference call regarding Q2 2022 results?

The conference call will be held at 6:00 a.m. Pacific Time on August 9, 2022.

Who will discuss Amyris' financial results during the conference call?

CEO John Melo and CFO Han Kieftenbeld will discuss the financial results during the call.

What markets does Amyris operate in?

Amyris operates in the Clean Health & Beauty and Flavors & Fragrances markets.

What is the purpose of Amyris' Lab-to-Market™ technology?

The Lab-to-Market™ technology accelerates the transition to sustainable consumption through innovative ingredient production.

Amyris Inc

NASDAQ:AMRS

AMRS Rankings

AMRS Latest News

AMRS Stock Data

Petroleum Refineries
Manufacturing
Link
US
Emeryville